{"id":140957,"date":"2026-08-05T17:28:40","date_gmt":"2026-08-05T17:28:40","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/140957\/"},"modified":"2026-08-05T17:28:40","modified_gmt":"2026-08-05T17:28:40","slug":"novo-nordisk-ceo-addresses-investors-high-wegovy-pill-expectations","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/140957\/","title":{"rendered":"Novo Nordisk CEO addresses investors&#8217; high Wegovy pill expectations"},"content":{"rendered":"<p>ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email<\/p>\n<p>Novo Nordisk hikes its 2026 outlook, but investors focus more on quarterly sales of the Danish pharma giant&#8217;s Wegovy weight loss pill, which came in slightly lower than expected. CEO Mike Doustdar addresses the expectations in a first on CNBC interview with Carolin Roth.<\/p>\n<p>08:41<\/p>\n<p>Wed, Aug 5 20264:27 AM EDT<\/p>\n","protected":false},"excerpt":{"rendered":"ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Novo Nordisk hikes its 2026&hellip;\n","protected":false},"author":2,"featured_media":140958,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[1275,8729,272],"class_list":["post-140957","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-business-news","tag-neutral","tag-novo-nordisk"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117044085211275099","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/140957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=140957"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/140957\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/140958"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=140957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=140957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=140957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}